|
|
||||||||
1Program in Integrative Cardiac Metabolism and 2Center for Cardiovascular Research, University of Illinois at Chicago, College of Medicine, Chicago, Illinois; and 3Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts
Submitted 29 March 2005 ; accepted in final form 12 October 2005
Triacylglycerol (TAG) storage and turnover rates in the intact, beating rat heart were determined for the first time using dynamic mode 13C- NMR spectroscopy to elucidate profound differences between hearts from diabetic rats (DR, streptozotocin treatment) and normal rats (NR). The incorporation of [2,4,6,8,10,12,14,16-13C8]palmitate into the TAG pool was monitored in isolated hearts perfused with physiological (0.5 mM palmitate, 5 mM glucose) and elevated substrate levels (1.2 mM palmitate, 11 mM glucose) characteristic of the diabetic condition. Surprisingly, although the normal hearts were enriched at a near-linear profile for
2 h before exponential characterization, exponential enrichment of TAG in diabetic hearts reached steady state after only 45 min. Consequently, TAG turnover rate was determined by fitting an exponential model to enrichment data rather than conventional two-point linear analysis. In the high-substrate group, both turnover rate (DR 820 ± 330, NR 190 ± 150 nmol·min1·g1 dry wt; P < 0.001) and [TAG] content (DR 78 ± 10, NR 32 ± 4 µmol/g dry wt; P < 0.001) were greater in the diabetic group. At lower substrate concentrations, turnover was greater in diabetics (DR 530 ± 300, NR 160 ± 30; P < 0.05). However, this could not be explained by simple mass action, because [TAG] content was similar between groups [DR 34 ± 7, NR 39 ± 9 µmol/g dry wt; not significant (NS)]. Consistent with exponential enrichment data, 13C fractional enrichment of TAG was lower in diabetics (low- substrate groups: DR 4 ± 1%, NR 10 ± 4%, P < 0.05; high-substrate groups: DR 8 ± 3%, NR 14 ± 9%, NS), thereby supporting earlier speculation that TAG is compartmentalized in the diabetic heart.
metabolism; nuclear magnetic resonance; palmitate; triglyceride; fatty acids
This article has been cited by other articles:
![]() |
K. M. Pound, N. Sorokina, K. Ballal, D. A. Berkich, M. Fasano, K. F. LaNoue, H. Taegtmeyer, J. M. O'Donnell, and E. D. Lewandowski Substrate-Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride Content: Attenuating Upregulated Anaplerosis in Hypertrophy Circ. Res., March 27, 2009; 104(6): 805 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Magnoni, E. Vaillancourt, and J.-M. Weber High resting triacylglycerol turnover of rainbow trout exceeds the energy requirements of endurance swimming Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R309 - R315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lehman, S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. The transcriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H185 - H196. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sorokina, J. M. O'Donnell, R. D. McKinney, K. M. Pound, G. Woldegiorgis, K. F. LaNoue, K. Ballal, H. Taegtmeyer, P. M. Buttrick, and E. D. Lewandowski Recruitment of Compensatory Pathways to Sustain Oxidative Flux With Reduced Carnitine Palmitoyltransferase I Activity Characterizes Inefficiency in Energy Metabolism in Hypertrophied Hearts Circulation, April 17, 2007; 115(15): 2033 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |